Diagnostic Management of Acute Pulmonary Embolism in COVID-19 and Other Special Patient Populations.

ABSTRACT: Venous thromboembolism (VTE), in particular acute pulmonary embolism (PE), has been shown to be a frequent and potentially fatal complication of coronavirus disease 2019 (COVID-19). In response to the observed thrombotic complications, a large number of studies has been devoted to the understanding and management of COVID-19-associated coagulopathy. Notably, only a limited number of mostly retrospective studies has focused on the optimal diagnostic strategy for suspected PE in COVID-19 patients. As in other special populations, the accuracy of diagnostic algorithms for PE-exclusion has been debated in this specific patient subgroup as the specificity of D-dimer assays and clinical decision rules (CDRs) may be lower than normal. From this viewpoint, we discuss the current state-of-the-art d

SUBMITTER: Martens ESL 

PROVIDER: S-EPMC9221574 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature